Atypical antipsychotics (APDs) are now the most widely used drugs in the treatment of several mental disorders such as schizophrenia, bipolar disorder and other severe behavioral disturbances [1]. Thanks to great patient benefits such as the reduction of serious side effects, for example extrapyramidal symptoms, including tardive dyskinesia and heart arrhythmias [2], APDs are replacing the traditional antipsychotics, butyrophenones and phenothiazines.
PKC-β activation and pharmacologically induced weight gain during antipsychotic treatment
PINTON, Paolo;Zavan B.
2011
Abstract
Atypical antipsychotics (APDs) are now the most widely used drugs in the treatment of several mental disorders such as schizophrenia, bipolar disorder and other severe behavioral disturbances [1]. Thanks to great patient benefits such as the reduction of serious side effects, for example extrapyramidal symptoms, including tardive dyskinesia and heart arrhythmias [2], APDs are replacing the traditional antipsychotics, butyrophenones and phenothiazines.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
